NCI Obligations by Mechanism
Other research mechanisms includes the following grants: Career Programs (K Awards), Cancer Education, Clinical Cooperative Groups, Pre-Doc Post-Doc Transition Awards, Education Projects - Cooperative Agreements, Minority Biomedical Research Support, Research Pathway in Residency, Pilot Research Project, Resource Grants, International Research Training grants, Cooperative Conference Agreements, Conference grants, and Other Transaction Authority (OTA).
$154,268,060
Type of Mechanism | Mechanism | Number | Amount | % of Total Amount |
---|---|---|---|---|
Research Project Grants (RPGs) | Noncompeting | 4,139 | $2,232,418,863 | 31.1% |
Administrative Supplements | 354 | $39,659,222 | 0.6% | |
Competing | 1,369 | $697,785,647 | 9.7% | |
Subtotal, without SBIR/STTR Grants | 5,508 | $2,969,863,732 | 41.3% | |
SBIR/STTR Grants | 228 | $175,373,048 | 2.4% | |
Subtotal, RPGs | 5,736 | $3,145,236,780 | 43.8% | |
Centers & SPOREs | Cancer Centers Grants-P20/P30 | 82 | $353,500,692 | 4.9% |
SPOREs | 63 | $124,109,217 | 1.7% | |
Other P50s/P20s | 4 | $5,302,188 | 0.1% | |
Other Specialized Centers | 100 | $141,526,500 | 2.0% | |
Subtotal, Centers | 249 | $624,438,597 | 8.7% | |
Other Research | Career Program | 0.0% | ||
Postdoc Fellow Awards-K00 | 81 | $7,511,395 | 0.1% | |
Research Scientist Development Award-K01 | 30 | $4,930,862 | 0.1% | |
Academic/Teacher Award-K07 | 1 | $636,196 | 0.0% | |
Clinical Investigator-K08 | 262 | $60,838,215 | 0.8% | |
Physician Scientist Award (Program)-K12 | 23 | $14,203,536 | 0.2% | |
Transitional Career Development-K22 | 60 | $11,108,024 | 0.2% | |
Mentored Quant. Res Career-K25 | 2 | $377,331 | 0.0% | |
International Research Career Development Award-K43 | 1 | $416,344 | 0.0% | |
Career Transition Award-K99 | 76 | $10,313,551 | 0.1% | |
Subtotal, Career Program | 536 | $110,335,454 | 1.5% | |
Cancer Education Program-R25 (including BD2K) | 83 | $23,218,691 | 0.3% | |
Clinical Cooperative Groups-U10/UG1 | 118 | $303,623,771 | 4.2% | |
Predoc Postdoc Transition Awards-F99 | 0 | $1,955,422 | 0.0% | |
Education Projects-UE5 | 0 | $528,237 | 0.0% | |
Minority Biomedical Support-S06 | 0 | $2,563,376 | 0.0% | |
Research Pathway in Residency-R38 | 0 | $1,233,360 | 0.0% | |
Other Transaction Authority-OT2 | $19,684,436 | 0.3% | ||
Resource Grants-R24/U24/U2C | 12 | 2.1% | ||
Cooperative Conference Agreements-U13/R13 | 0 | $1,050,263 | 0.0% | |
International Research Training Grants Conference-D43 | 0 | $3,039,704 | 0.0% | |
International Training Cooperative Agreement-U2R | 0 | $0 | 0.0% | |
Subtotal, Career and Other Research Grants | 749 | $621,500,774 | 8.6% | |
Subtotal, Research Grants | 6,734 | $4,391,876,151 | 61.1% | |
National Research Service Award (NRSA) Fellowships | Trainees | 1,559 | $90,324,558 | 1.3% |
R&D Contracts | R&D Contracts | 409 | $738,215,732 | 10.3% |
SBIR Contracts | 29 | $24,397,507 | 0.3% | |
NIH Management Fund/SSF Assessment | 0 | $136,456,932 | 1.9% | |
Subtotal, Contracts | 438 | $899,070,171 | 12.5% | |
Intramural Research | Program | 1,865 | $983,006,934 | 13.7% |
NIH Management Fund/SSF Assessment | 0 | $295,537,156 | 4.1% | |
Subtotal, Intramural Research (FTEs) | 1,865 | $1,278,544,090 | 17.8% | |
Research Management & Support (RMS) | Research Management and Support (RMS) | 1,385 | $384,080,402 | 5.3% |
SBIR RMS | 0 | $3,483,639 | 0.0% | |
NIH Management Fund/SSF Assessment | 0 | $110,222,485 | 1.5% | |
Subtotal, RMS (FTEs) | 1,385 | $497,786,526 | 6.9% | |
Buildings & Facilities | 0 | $30,000,000 | 0.4% | |
*Total NCI | (FTEs) | 3,250 | $7,187,601,496 | 100.0% |
All items in italics are non-add entries. *Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |
Division Obligations by Mechanism
Division Obligations
Division | Total |
---|---|
Center for Cancer Research (CCR) | $598,072,228 |
Division of Cancer Epidemiology and Genetics (DCEG) | $115,754,029 |
Division of Cancer Treatment and Diagnosis (DCTD) | $595,710,724 |
Division of Cancer Biology (DCB) | $59,954,941 |
Division of Cancer Control and Population Sciences (DCCPS) | $153,317,190 |
Division of Cancer Prevention (DCP) | $238,130,638 |
Division of Extramural Activities (DEA) | $21,813,439 |
Office of the Director (OD) | $1,724,988,746 |
Total Division | $6,535,805,879 |
*Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |
Center for Cancer Research (CCR)
Type of Mechanism | Mechanism | Amount |
---|---|---|
Intramural Research | Program | $598,072,228 |
NIH Management Fund | $0 | |
Total CCR | $598,072,228 | |
*Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |
Division of Cancer Epidemiology and Genetics (DCEG)
Type of Mechanism | Mechanism | Amount |
---|---|---|
R&D Contracts | R&D Contracts | $15,304,016 |
SBIR Contracts | $0 | |
Subtotal, Contracts | $15,304,016 | |
Intramural Research | Program | $100,450,013 |
NIH Management Fund | $0 | |
Subtotal, Intramural Research | $100,450,013 | |
Total DCEG | $115,754,029 | |
*Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |
Division of Cancer Treatment and Diagnosis (DCTD)
Type of Mechanism | Mechanism | Amount |
---|---|---|
Centers & SPOREs | Cancer Centers Grants-P20/P30 | $0 |
SPOREs-P50 | $117,621,136 | |
Other P50s/P20s | $0 | |
Other Specialized Centers | $18,086,776 | |
Subtotal, Centers | $135,707,912 | |
Other Research–Grants | Cancer Education Program-R25 (including BD2K) | $0 |
Education Projects-UE5 | $0 | |
Clinical Cooperative Groups-U10/UG1 | $143,878,408 | |
PreDoc PostDoc Transition Awards-F99 | $0 | |
Minority Biomedical Support-S06 | $0 | |
Rsrch Pathway in Residency-R38 | $0 | |
Pilot Research Project-OT2 | $0 | |
Resource Grants-R24/U24/U2C | $0 | |
Cooperative Conference Agreements-U13/R13 | $0 | |
International Research Training Grant-D43 | $0 | |
International Training Cooperative Agreement-U2R | $0 | |
Subtotal, Other Research-Grants | $143,878,408 | |
Subtotal, Research Grants | $279,586,320 | |
R&D Contracts | R&D Contracts | $248,976,185 |
SBIR Contracts | $0 | |
NIH Management Fund/SSF Assessment | $0 | |
Subtotal, Contracts | $248,976,185 | |
Research Management & Support (RMS) | RMS | $67,148,219 |
SBIR RMS | $0 | |
NIH Management Fund/SSF Assessment | $0 | |
Subtotal, RMS | $67,148,219 | |
Total DCTD | $595,710,724 | |
*Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |
Division of Cancer Biology (DCB)
Type of Mechanism | Mechanism | Amount |
---|---|---|
Centers & SPOREs | Cancer Centers Grants-P20/P30 | $0 |
SPOREs-P50 | $0 | |
Other P50s/P20s | $587,068 | |
Other Specialized Centers | $44,316,999 | |
Subtotal, Centers | $44,904,067 | |
Other Research-Grants | Subtotal, Other Research–Grants | $0 |
Subtotal, Research Grants | $44,904,067 | |
| R&D Contracts | $66,552 |
SBIR Contracts | $0 | |
NIH Management Fund/SSF Assessment | $0 | |
Subtotal, Contracts | $66,552 | |
Research Management & Support (RMS) | RMS | $14,984,322 |
SBIR RMS | $0 | |
NIH Management Fund | $0 | |
Subtotal, RMS | $14,984,322 | |
Total DCB | $59,954,941 | |
*Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |
Division of Cancer Control and Population Sciences (DCCPS)
$10,120,819
Type of Mechanism | Mechanism | Amount |
---|---|---|
Centers & SPOREs | Cancer Centers Grants-P20/P30 | $0 |
SPOREs-P50 | $0 | |
Other P50s/P20s | $5,302,188 | |
Other Specialized Centers | ||
Subtotal, Centers | $15,423,007 | |
Other Research-Grants | Cancer Education Program-R25 (including BD2K) | $0 |
Education Projects-UE | $0 | |
Clinical Cooperative Groups-U10/UG1 | $0 | |
PreDoc PostDoc Transition Awards-F99 | $0 | |
Minority Biomedical Support-S06 | $0 | |
Research Pathway in Residency-R38 | $0 | |
Pilot Research Project-OT2 | $0 | |
Resource Grants-R24/U24/U2C | $0 | |
Cooperative Conference Agreements-U13/R13 | $0 | |
International Research Training Grants-D43 | $0 | |
International Training Cooperative Agreement-U2R | $0 | |
Subtotal, Other Research Grants | $0 | |
Subtotal, Research Grants | $15,423,007 | |
R&D Contracts | R&D Contracts | $95,860,843 |
SBIR Contracts | $0 | |
NIH Management Fund/SSF Assessment | $0 | |
Subtotal, Contracts | $95,860,843 | |
Research Management & Support (RMS) | RMS | $42,033,340 |
SBIR RMS | $0 | |
NIH Management Fund | $0 | |
Subtotal, RMS | $42,033,340 | |
Total DCCPS | $153,317,190 | |
*Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |
Division of Cancer Prevention (DCP)
Type of Mechanism | Mechanism | Amount |
---|---|---|
Centers & SPOREs | Cancer Centers Grants-P20/P30 | $0 |
SPOREs-P50 | $0 | |
Other P50s/P20s | $0 | |
Other Specialized Centers | $10,110,005 | |
Subtotal, Centers | $10,110,005 | |
Other Research–Grants | Cancer Education Program-R25 (including BD2K) | $0 |
UE5 Education Projects | $0 | |
Clinical Cooperative Groups-U10/UG1 | $153,267,629 | |
PreDoc PostDoc Transition Awards-F99 | $0 | |
Minority Biomedical Support-S06 | $0 | |
Rsrch pathway in Residency-R38 | $0 | |
Pilot Research Project-OT2 | $0 | |
Resource Grants-R24/U24/U2C | $0 | |
Cooperative Conference Agreements-U13/R13 | $0 | |
International Research Training Grants-D43 | $0 | |
International Training Cooperative Agreement-U2R | $0 | |
Subtotal, Other Research Grants | $153,267,629 | |
Subtotal, Research Grants | $163,377,634 | |
R&D Contracts | R&D Contracts | $45,967,374 |
SBIR Contracts | $0 | |
NIH Management Fund/SSF Assessment | $0 | |
Subtotal, Contracts | $45,967,374 | |
Research Management & Support (RMS) | RMS | $28,785,630 |
SBIR RMS | $0 | |
NIH Management Fund/SSF Assessment | $0 | |
Subtotal, RMS | $28,785,630 | |
Total DCP | $238,130,638 | |
*Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |
Division of Extramural Activities (DEA)
Type of Mechanism | Mechanism | Amount |
---|---|---|
Research Management & Support (RMS) | RMS | $21,813,439 |
SBIR RMS | $0 | |
NIH Management Fund | $0 | |
Total DEA | $21,813,439 | |
*Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |
Office of the Director (OD)
$88,434,849
Type of Mechanism | Mechanism | Amount |
---|---|---|
Research Project Grants (RPGs) | Noncompeting | $0 |
Administrative Supplements | $0 | |
Competing | $0 | |
Subtotal, without SBIR/STTR Grants | $0 | |
SBIR/STTR Grants-R41 -44 | $175,373,048 | |
Subtotal, RPGs | $175,373,048 | |
Centers & SPOREs | Cancer Centers Grants-P20/P30 | $352,913,624 |
SPOREs | $4,348,587 | |
Other P50s/P20s | $0 | |
Other Specialized Centers | $60,668,325 | |
Subtotal, Centers | $417,930,536 | |
Other Research–Career Program | Career Program | $0 |
Post-Doc-Fellow Awards-K00 | $7,511,395 | |
Research Scientist Development Award-K01 | $4,930,862 | |
Research Scientist Award-K05 | $0 | |
Academic/Teacher Award-K07 | $636,196 | |
Clinical Investigator-K08 | $60,838,215 | |
Physician Scientist Award (Program)-K12 | $14,203,536 | |
Transitional Career Development-K22 | $11,108,024 | |
Mentored Patient Oriented RCDA-K23 | $0 | |
Mid-Career Invest. & Patient Orient. Res-K24 | $0 | |
Mentored Quant. Res Career-K25 | $377,331 | |
International Research Career Development Award-K43 | $416,344 | |
Career Transition Award-K99 | $10,313,551 | |
Subtotal, Career Program | $110,335,454 | |
Other Research–Grants | Cancer Education Program-R25 (including BD2K) | $23,218,691 |
Education Projects-UE5 | $0 | |
Clinical Cooperative Groups-U10/UG1 | $6,477,734 | |
PreDoc PostDoc Transition Awards-F99 | $0 | |
Minority Biomedical Support-S06 | $0 | |
Rsrch Pathway in Residency-R38 | $0 | |
Pilot Research Project-OT2 | $0 | |
Resource Grants-R24/U24/U2C | $19,496,381 | |
Cooperative Conference Agreements-U13/R13 | $0 | |
International Research Training Grants-D43 | $0 | |
International Training Cooperative Agreement-U2R | $0 | |
Subtotal, Other Research–Grants | $49,192,806 | |
Subtotal, Research Grants | $752,831,844 | |
NRSA Fellowships | ||
R&D Contracts | R&D Contracts | $332,040,762 |
SBIR Contracts | $24,397,507 | |
NIH Management Fund/SSF Assessment/Program Evaluation | $0 | |
Subtotal, Contracts | $356,438,269 | |
Intramural Research | Program | $284,484,693 |
NIH Management Fund/SSF Assessment/Program Evaluation | $0 | |
Subtotal, Intramural Research | $284,484,693 | |
Research Management & Support (RMS) | RMS | $209,315,452 |
SBIR RMS | $3,483,639 | |
NIH Management Fund/SSF Assessment/Program Evaluation | $0 | |
Subtotal, RMS | $212,799,091 | |
Buildings and Facilities | $30,000,000 | |
Total OD | $1,724,988,746 | |
*Includes FY23 Cures-Moonshot funding. *Excludes FY22 through FY17 Cures-Moonshot carryover obligations. |